Rare diseases
Investigational molecules
Locations
Back to France57 clinical trials in Saint-Mande, France. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Long‑term Safety of Adagrasib with Drug Combination in Adults with Solid Tumors
FranceRemibrutinib in Chronic Spontaneous Urticaria for Patients Who Benefited from a Previous Remibrutinib Trial
FranceA safety and efficacy study of SAR445399 in adults with moderate to severe hidradenitis suppurativa
FranceA study comparing trifluridine, tipiracil, and fruquintinib versus trifluridine and tipiracil alone for patients with metastatic stomach or esophageal cancer
FranceStudy on Chemotherapy for Patients with Resected Pancreatic Cancer Using FOLFIRINOX and Drug Combination
FranceStudy on Optimizing NALIRIFOX and 5-FU for Metastatic Pancreatic Cancer in First-Line Treatment and Exploring Ciprofloxacin in Second-Line Therapy
FranceStudy on Hyperthermic Intraperitoneal Chemotherapy with Cisplatin for Patients with Recurrent Ovarian Cancer
FranceStudy on EXL01 with Nivolumab and FOLFOX for First-Line Treatment in Patients with PD-L1 CPS ≥5 Metastatic Gastric Cancer
FranceStudy on Cabozantinib and Drug Combination for Untreated Metastatic Renal Cell Carcinoma in Intermediate and Poor Risk Patients
FranceStudy on 68Ga-FAPI-46 for Predicting Treatment Response in Early-Stage High-Risk Triple-Negative Breast Cancer Patients Undergoing Chemo-Immunotherapy
FranceStudy on Botulinum Toxin A Injection for Patients with Large Incisional Hernia
FranceStudy on the Effectiveness of Chemotherapy with Folinic Acid, Fluorouracil, and Irinotecan for Patients with Stage III Colon Cancer After Surgery
FranceThe busiest research cities in the country
What the registry says about research in the country
Extensive clinical trials focusing on non-small cell lung cancer (NSCLC) evaluating novel immunotherapy combinations and treatment approaches for both early-stage and metastatic disease.
Studies incorporate cutting-edge targeted therapies and innovative treatment strategies for different patient populations.
Research initiatives examining treatments for castration-resistant prostate cancer, including novel drug combinations and therapeutic approaches for both localized and metastatic disease.
Investigations focus on improving survival outcomes and treatment efficacy for various stages of prostate cancer.
Clinical trials exploring treatments for colorectal cancer and advanced gastric cancer, investigating innovative therapeutic combinations and targeted approaches.
Studies aim to advance personalized treatment strategies and improve patient outcomes.
Research focusing on chronic skin conditions including hidradenitis suppurativa and atopic dermatitis, testing new biological therapies.
Trials aim to develop more effective treatments for challenging dermatological conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
